Search - tctmd.com

Displaying 61 - 80 of 576

Sort: Relevancy | Date

Scientific Statement Reviews Current Antithrombotic Options in PAD

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

August 26, 2024

Platelet Hyperreactivity Score May Improve CVD Risk Detection

News Daily News

Platelet Hyperreactivity Score May Improve CVD Risk Detection

August 23, 2024

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

News Daily News

New Data Reassure on Rivaroxaban’s Role in Frail PAD Patients

August 19, 2024

August 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

August 2024 Dispatch for the CV Team

August 01, 2024

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

News Daily News

Burden of CVD Still High in UK Despite Prevention Efforts Over 20 Years

Yael L. Maxwell

June 26, 2024

June 2024 Dispatch for the CV Team

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

June 01, 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

News Conference News ESOC 2024

Thrombectomy’s Benefits in Large-Core Strokes Sustained at 1 Year: TENSION

May 22, 2024

LASTE Shows Thrombectomy Helps for Large Strokes of All Sizes

News Daily News

LASTE Shows Thrombectomy Helps for Large Strokes of All Sizes

May 10, 2024

TCTMD’s Top 10 Most Popular Stories for April 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2024

April 30, 2024

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

News Daily News

DETECT: No Long-term Harm From Paclitaxel Devices in PAD

March 25, 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

News Conference News CRT 2024

CLIPPER: Emphasis on Faster Revascularization Could Change CLTI Care

March 20, 2024

TCTMD’s Top 10 Most Popular Stories for February 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2024

March 01, 2024

Mechanism’s Mojo ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

News Conference News ISC 2024

Radial Access for Acute Stroke Interventions Takes Longer, No Safety Gains

February 12, 2024

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

News Conference News ISC 2024

Thrombectomy Advantage for Large-Core Strokes Widens Over 12 Months: TESLA

February 09, 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

News Conference News ISC 2024

MOST: Eptifibatide, Argatroban Don’t Improve on IV Thrombolysis Alone

February 08, 2024

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

News Conference News ISC 2024

ZODIAC: Laying Flat Equals Better Outcomes for Stroke Thrombectomy Candidates

February 08, 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

News Conference News ISET 2024

AI in Pulmonary Embolism: ‘Transformative’ for Patient Care

January 30, 2024

DOAC Don’ts New Review Clarifies When Not to Use Direct Oral Anticoagulants

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

January 17, 2024

AHA Selects 2023’s Leading Cardiovascular Research

News Daily News

AHA Selects 2023’s Leading Cardiovascular Research

December 22, 2023

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.